Embolie pulmonaire aiguë chez les patients atteints de COVID-19, une étude rétrospective multicentrique

Hamid, A.; Mourtada, L.; Barake, R.; Trimech, T.R.; Nay, L.E.; Cherif, G.; Montagnon, S.; Haussman, J.; Allard, Isabelle; Ajlani, B.; Chayeb, S.; Laize, H.; Achkar, A.

doi:10.1016/j.rmra.2020.11.308

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This increase in D-dimer is an independent biomarker of poor prognosis in COVID-19 disease [9]. Cohort studies have shown that thromboembolic complications in patients with covid 19 ranged from 11 to 35% [10,11].…”

Section: Discussionmentioning

confidence: 99%

Pulmonary Embolism in Patients with COVID-19: Retrospective Study of Ten (10) Cases at the Renaissance University Hospital of N'Djamena/Chad

Doune¹

2022

J Cardiol Cardiovasc Res

View full text Add to dashboard Cite

Introduction: Venous thromboembolic events are encountered during the course of COVID-19, the main one being pulmonary embolism, which shares clinical manifestations. The objective of this study is to recognize the arguments that can evoke a pulmonary embolism in a patient with COVID-19. Patients and methods: This was a case-control study conducted over 6 months at the renaissance university hospital. We collected ten (10) records of covid 19 patients diagnosed with pulmonary embolism representing the cases, and twenty (20) records of covid 19 patients without pulmonary embolism (controls). Results: Five (05) patients (50%) had a comorbidity. The thromboembolic risk factor found was prolonged bed rest. The symptoms were: cough and fever (0.3%), dyspnea and chest pain (0.2%), fever and dyspnea (0.3%) and other symptoms (0.2%) p=0.3. Arterial hypotension (70%) normal blood pressure (10%) and hypertension (20%) p=0.9. Electrical abnormalities were found in 60% of patients and dominated by rhythm disorders (40%), p=0.29. At admission, 10% of patients had a saturation of less than 90% and 90% had a saturation of more than 90%, p=0.48. The d-dimer level from 5 times abore normal represented 90% p=0.007. High CRP and below 20 mg/l (20%) from 20-100mg/l (60%) and above 100 mg/l (20%) p=0.27. All received effective anticoagulation with enoxaparin. Thirty percent (30%) died and 70% returned home on oral anticoagulation (57% vitamin K antagonist and 43% direct oral anticoagulants). Conclusion: Pulmonary embolism in covid 19 is difficult to diagnose. An elevation of d-dimer may suggest the diagnosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Pulmonary Embolism in Patients with COVID-19: Retrospective Study of Ten (10) Cases at the Renaissance University Hospital of N'Djamena/Chad

Doune¹

2022

J Cardiol Cardiovasc Res

View full text Add to dashboard Cite

show abstract

Embolie pulmonaire aiguë chez les patients atteints de COVID-19, une étude rétrospective multicentrique

Cited by 1 publication

References 0 publications

Pulmonary Embolism in Patients with COVID-19: Retrospective Study of Ten (10) Cases at the Renaissance University Hospital of N'Djamena/Chad

Pulmonary Embolism in Patients with COVID-19: Retrospective Study of Ten (10) Cases at the Renaissance University Hospital of N'Djamena/Chad

Contact Info

Product

Resources

About